INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 98 filers reported holding INHIBRX INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $203,000 | – | 9,135 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,023,325 | $11,615,000 | 3.23% |
| Opaleye Management Inc. | 590,000 | $6,697,000 | 3.02% |
| Sio Capital Management, LLC | 365,210 | $4,145,000 | 1.56% |
| Perceptive Advisors | 1,914,592 | $21,731,000 | 0.68% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 794,682 | $9,020,000 | 0.65% |
| Birchview Capital, LP | 70,448 | $800,000 | 0.58% |
| Meridian Wealth Advisors, LLC | 122,315 | $1,388,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 5,305,866 | $60,222,000 | 0.28% |
| ArrowMark Colorado Holdings LLC | 1,412,236 | $16,029,000 | 0.18% |
| Alaethes Wealth LLC | 19,341 | $220,000 | 0.16% |